Endothelin Blockade in Diabetic Kidney Disease

Diabetic kidney disease (DKD) remains the most common cause of chronic kidney disease and multiple therapeutic agents, primarily targeted at the renin-angiotensin system, have been assessed. Their only partial effectiveness in slowing down progression to end-stage renal disease, points out an eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Anguiano, Lidia, Riera, Marta, Pascual, Julio, Soler, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484993/
https://www.ncbi.nlm.nih.gov/pubmed/26239552
http://dx.doi.org/10.3390/jcm4061171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484993/
https://www.ncbi.nlm.nih.gov/pubmed/26239552
http://dx.doi.org/10.3390/jcm4061171

Ejemplares similares